Ursula Halwachs
YOU?
Author Swipe
View article: Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab – a case report
Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab – a case report Open
Much excitement has been generated with the approval of idarucizumab, a humanized monoclonal antigen‐binding antibody fragment that is capable of reversing the anticoagulant activity of dabigatran. Here, we describe our initial experience …